ANTH (Anthera Pharmaceuticals) Net Margin %: 0.00% (As of Mar. 2018)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Anthera Pharmaceuticals Net Margin %?

Anthera Pharmaceuticals ANTH Net Margin % is 0.00% as of Mar. 2018.

Net margin is calculated as Net Income divided by its Revenue. Anthera Pharmaceuticals's Net Income for the three months ended in Mar. 2018 was $-7.72 Mil. Anthera Pharmaceuticals's Revenue for the three months ended in Mar. 2018 was $0.00 Mil. Therefore, Anthera Pharmaceuticals's net margin for the quarter that ended in Mar. 2018 was 0.00%.

The historical rank and industry rank for Anthera Pharmaceuticals's Net Margin % or its related term are showing as below:


ANTH's Net Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -76.745
* Ranked among companies with meaningful Net Margin % only.

Anthera Pharmaceuticals  (OTCPK:ANTH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Anthera Pharmaceuticals Net Margin % Related Terms

Anthera Pharmaceuticals Net Margin % Historical Data

* Premium members only.

The historical data trend for Anthera Pharmaceuticals's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anthera Pharmaceuticals Net Margin % Chart

Anthera Pharmaceuticals Annual Data
Trend Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -1,105.81 -38,291.72 0.00

Anthera Pharmaceuticals Quarterly Data
Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ANTH vs TIKRF, CAPS, AKAOQ: Net Margin % Comparison

For the Biotechnology subindustry, Anthera Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anthera Pharmaceuticals Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Anthera Pharmaceuticals's Net Margin % distribution charts can be found below:

* The bar in red indicates where Anthera Pharmaceuticals's Net Margin % falls into.


Anthera Pharmaceuticals Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Anthera Pharmaceuticals's Net Margin for the fiscal year that ended in Dec. 2017 is calculated as

Net Margin=Net Income (A: Dec. 2017 )/Revenue (A: Dec. 2017 )
=-26.874/0
= %

Anthera Pharmaceuticals's Net Margin for the quarter that ended in Mar. 2018 is calculated as

Net Margin=Net Income (Q: Mar. 2018 )/Revenue (Q: Mar. 2018 )
=-7.724/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Anthera Pharmaceuticals (ANTH) has a Net Margin % of 0.00% as of Mar. 2018. Net margin is the ratio of total net income to net sales. View historical data on Anthera Pharmaceuticals and its competitors.
Is Anthera Pharmaceuticals' Net Margin % too high?
Anthera Pharmaceuticals' current Net Margin % is 0.00%.
How does Anthera Pharmaceuticals' Net Margin % compare to TIKRF and CAPS?
Anthera Pharmaceuticals' Net Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Anthera Pharmaceuticals and its competitors. Anthera Pharmaceuticals's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthera Pharmaceuticals stock overvalued right now?
Anthera Pharmaceuticals (ANTH) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Anthera Pharmaceuticals (ANTH), the current Net Margin % is 0.00% as of Mar. 2018. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Anthera Pharmaceuticals Business Description

Address 700 Milam, Suite 1300, Houston, TX, USA, 77002
Anthera Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. The company currently has one Phase 3-ready clinical program and two Phase 2 clinical programs. It was established in 2004.